Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.55 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.55 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.55 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.55 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.55 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL329461 | 1.00 | TSHR (0.55) | TSHRCYP3A4LMNAGABRA1GABRG2 | |
| SCHEMBL10012314 | 1.00 | TSHR (0.55) | TSHRCYP3A4LMNAGABRA1GABRG2 | |
| SCHEMBL17022282 | 1.00 | TSHR (0.55) | TSHRCYP3A4LMNAGABRA1GABRG2 | |
| SCHEMBL15586623 | 1.00 | TSHR (0.55) | TSHRCYP3A4LMNAGABRA1GABRG2 | |
| SCHEMBL3004 | 1.00 | TSHR (0.55) | TSHRCYP3A4LMNAGABRA1GABRG2 | |
| SCHEMBL2024638 | 1.00 | TSHR (0.55) | TSHRCYP3A4LMNAGABRA1GABRG2 | |
| SCHEMBL7097318 | 0.97 | TSHR (0.52) | TSHRCYP3A4LMNAGABRA1GABRG2 | |
| Hydrochloric Acid SCHEMBL11523265 | 0.97 | TSHR (0.52) | TSHRCYP3A4LMNAGABRA1GABRG2 | |
| Fluoride SCHEMBL11751487 | 0.97 | TSHR (0.52) | TSHRCYP3A4LMNAGABRA1GABRG2 | |
| SCHEMBL11696325 | 0.97 | TSHR (0.52) | TSHRCYP3A4LMNAGABRA1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113646941-B | Electrolyte solution for lithium secondary battery and lithium secondary battery comprising same | 株式会社LG新能源 | 2024-07-02 | — | — | CN | claimed |
| CN-113646941-A | Electrolyte solution for lithium secondary battery and lithium secondary battery including the same | 株式会社LG新能源 | 2021-11-12 | — | — | CN | claimed |
| EP-2352198-B1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY COMPRISING THE SAME | LG CHEMICAL LTD (KR) | 2014-10-15 | — | — | EP | claimed |
| EP-1888544-A2 | HYDROXYSTEROID DEHYDROGENASE INHIBITORS | Takeda San Diego, Inc. (US) | 2008-02-20 | — | — | EP | claimed |
| WO-2006066109-A2 | HYDROXYSTEROID DEHYDROGENASE INHIBITORS | TAKEDA SAN DIEGO, INC. (US) | 2006-06-22 | — | — | WO | claimed |
| JP-56120642-A | — | — | None | — | — | JP | disclosed |
| CN-113646941-B | Electrolyte solution for lithium secondary battery and lithium secondary battery comprising same | 株式会社LG新能源 | 2024-07-02 | — | — | CN | disclosed |
| EP-4366733-A1 | TETRAHYDROPYRAZOLOPYRIDINE-ANALOG LIGANDS OF NLRX1 AND USES THEREOF | LANDOS BIOPHARMA, INC. (US) | 2024-05-15 | — | — | EP | disclosed |
| CN-117835980-A | Tetrahydropyrazolopyridine analog ligand of NLRX1 and application thereof | 朗多生物制药股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| EP-3927427-B1 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | NIMMUNE BIOPHARMA INC (US) | 2024-02-07 | — | — | EP | disclosed |
| US-20230357744-A1 | ENGINEERED TRYPTOPHAN DECARBOXYLASES AND USES THEREOF FOR SYNTHESIZING TRYPTAMINE ANALOGS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-11-09 | — | — | US | disclosed |
| EP-4225315-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING INFLAMMATORY OR IMMUNE-MEDIATED CONDITIONS OF SURFACE TISSUES | Nimmune Biopharma, Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| EP-1565509-A1 | CATALYTIC COMPOSITION OF ORGANOTIN COMPOUNDS | Crompton GmbH (DE) | 2005-08-24 | — | — | EP | disclosed |
| WO-2004050742-A1 | CATALYTIC COMPOSITION OF ORGANOTIN COMPOUNDS | CROMPTON GMBH (DE) | 2004-06-17 | — | — | WO | disclosed |
| US-20030161941-A1 | Transparent polythiophene layers of high conductivity | BAYER AKTIENGESELLSCHAFT (DE) | 2003-08-28 | — | — | US | disclosed |
| EP-1338617-A2 | Transparant layers of Polythiophene having high conductivity | Bayer Aktiengesellschaft (DE) | 2003-08-27 | — | — | EP | disclosed |
| CN-1438656-A | Transparent polythiofuran layer of high conductivity | BAYER AG (DE) | 2003-08-27 | — | — | CN | disclosed |
| JP-S56120642-A | PREPARATION OF ARYL ESTER OF AROMATIC OXYCARBOXYLIC ACID | TEIJIN LTD | 1981-09-22 | — | — | JP | disclosed |
| US-4159267-A | Novel silyl ester azetidine-2-sulfenate intermediates and process for preparing desacetoxycephalosporins | ELI LILLY AND COMPANY (US) | 1979-06-26 | — | — | US | disclosed |
| US-3944545-A | Process for preparing desacetoxycephalosporins | ELI LILLY AND COMPANY (US) | 1976-03-16 | — | — | US | disclosed |